HSA approves Pfizer’s new RSV vaccine

Jewel Stolarchuk
Wed, 25 Sep 2024 09:17:27 +0000
Singapore News, HSA, Pfizer, RSV, vaccine

SINGAPORE: The Health Sciences Authority (HSA) has approved Pfizer’s respiratory syncytial virus (RSV) vaccine, Abrysvo, marking a milestone in preventing lower respiratory tract disease (LRTD) in vulnerable groups. This is the first RSV vaccine approved in Singapore for use in older adults and pregnant individuals, providing critical protection to infants and seniors. Pfizer Singapore made …